Keywords: lilly, licenses, raloxifene, chugai, eli, licensed, its

Lilly Licenses Raloxifene To Chugai

Article | 18 December 1995

Print This

Eli Lilly has licensed its estrogen receptor modulator, raloxifene, to Chugai for codevelopment and comarketing in the Japanese market. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in